Clinical Trial Update: Bendamustine and Rituximab in Combination With Copanlisib for the Treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial investigating bendamustine and rituximab in combination with copanlisib for chronic lymphocytic leukemia or small lymphocytic lymphoma has been te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Lymphoid Leukemia
• Non-hodgkin Lymphoma
• Small Lymphocytic Lymphoma

Drugs mentioned

• Bendamustine (Bendamustine)
• Copanlisib (copanlisib)
• Rituximab (rituximab)

Snippet

Sponsor: University of Washington | Conditions: Lymphoid Leukemia, Non-Hodgkin's Lymphoma | Phase 2 | Status: TERMINATED | Results posted: 2022-04-11